Vendor, The Woodlands, TX, part of Mckesson Corporation
Mckesson Specialty Health Pharmaceutical & Biotech Solutions LLC
UEI GWZXFMRKFS27, CAGE 9GTD5
2 awards and $23,718 obligated between March 25, 2024 and September 23, 2025, 50% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Department of Veterans Affairs | $23,718 |
| Food and Drug Administration | $0 |
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $23,718 |
| Research and Development in the Social Sciences and HumanitiesNAICS 541720 | $0 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Full and Open Competition | 1 |
| Purchase Order | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36C25725P0508Purchase Order, May 30, 2025, Not Competed Under SAP, 1 offers | 257-Network Contract Office 17Department of Veterans Affairs | Humatin Usp Caps 250MGNAICS 325412, PSC Q517 | $23,718 |
| 75F40123C00199Definitive Contract, March 25, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Leveraging Real-World Data (Rwd) to Investigate the Natural History of Rare Cancers Treated in the US Community Oncology Setting to Provide NAICS 541720, PSC B529 | $0 |
- Places of performance
- Texas
- Product and service codes
- Q517 Pharmacy ServicesB529 Scientific Data Studies
- Transactions
- 3 across 2 awards